Memuat...

Advertisement

Vir Biotechnology Appoints Mark Eisner As EVP And Chief Medical Officer

RTTNews | 454 hari yang lalu

Vir Biotechnology Appoints Mark Eisner As EVP And Chief Medical Officer

(RTTNews) - Immunology company Vir Biotechnology, Inc. (VIR) announced Wednesday that Mark Eisner will join the company as Executive Vice President and Chief Medical Officer (CMO), effective June 03, 2024.

Eisner will be a part of the company's Executive Management Team and will report directly to Chief Executive Officer Marianne De Backer.

Eisner brings to Vir deep immunology and infectious disease expertise with clinical development experience. He has an impressive track record of leading teams during times of strategically evolving portfolios.

Eisner comes from Sonoma Biotherapeutics, where he most recently held the position of CMO. Prior to his most recent tenure with Sonoma, Eisner served as CMO at FibroGen where he led all development functions, which included being the Head of China clinical development and clinical operations.

Eisner has also been with Genentech nearly 11 years and served as their Senior Vice President of Global Head of Product Development Immunology, Infectious Disease and Ophthalmology.

Teg: VIR

read more

U.S. Consumer Confidence Index Edges Lower In August

U.S. Consumer Confidence Index Edges Lower In August

A report released by the Conference Board on Tuesday showing a modest deterioration by consumer confidence in the U.S. in the month of August. The Conference Board said its consumer confidence index dipped to 97.4 in August from an upwardly revised 98.7 in July.

RTTNews | 3j 14min yang lalu

U.S. Durable Goods Orders Slump 2.8% In July, Much Less Than Expected

U.S. Durable Goods Orders Slump 2.8% In July, Much Less Than Expected

Reflecting a continued plunge by orders for transportation equipment, the Commerce Department released a report on Tuesday showing a steep drop by new orders for U.S. manufactured durable goods in the month of July. The Commerce Department said durable goods orders slumped by 2.8 percent in July after plummeting by a revised 9.4 percent in June.

RTTNews | 3j 26min yang lalu

Bay Street May Open On Weak Note

Bay Street May Open On Weak Note

Canadian shares look headed for negative start on Tuesday, weighed down by weak oil prices, and concerns about global trade after U.S. President Donald Trump threatened 200% tariffs on China if Beijing does not export rare-earth magnets to the U.S.

RTTNews | 4j 44min yang lalu

U.S. Durable Goods Orders Tumble Less Than Expected In July

U.S. Durable Goods Orders Tumble Less Than Expected In July

Reflecting a continued plunge by orders for transportation equipment, the Commerce Department released a report on Tuesday showing a steep drop by new orders for U.S. manufactured durable goods in the month of July.

RTTNews | 4j 50min yang lalu

FTSE 100 Modestly Lower

FTSE 100 Modestly Lower

After posting gains in the previous five sessions, the U.K. market is exhibiting weakness on Tuesday, weighed down by losses in financials and retail sectors.

RTTNews | 5j 12min yang lalu

CAC Down Sharply On Widespread Selling

CAC Down Sharply On Widespread Selling

French stocks are down sharply on Tuesday, extending previous session's steep drop, amid ongoing political uncertainty in the country.

RTTNews | 5j 37min yang lalu

DAX Extending Recent Weakness

DAX Extending Recent Weakness

German stocks are down in negative territory on Tuesday, extending losses from the previous session, due to geopolitical concerns and uncertainty about tariffs.

RTTNews | 7j 0min yang lalu

Sensex, Nifty Tumble On Tariff Worries

Sensex, Nifty Tumble On Tariff Worries

Indian shares tumbled on Tuesday after the Trump administration officially issued a notice regarding the imposition of an additional 25 percent tariffs on Indian imports, with the punitive duties set to kick in at 12:01 am (EST) on August 27.

RTTNews | 7j 4min yang lalu

Syarat | Privasi | Peta Laman | Site Map Calendar

&salin; 2025 Myfxbook Ltd. Hak Cipta Terpelihara.

PERINGATAN RISIKO TINGGI: Perdagangan pertukaran mata wang asing mempunyai risiko tinggi yang mungkin tidak sesuai untuk semua jenis pelabur. Leveraj menimbulkan risiko dan kerugian tambahan. Sebelum anda memutuskan untuk berdagang pertukaran mata wang asing, pertimbangkan dengan teliti objektif pelaburan, tahap pengalaman dan toleransi risiko anda. Anda berkemungkinan kehilangan sebahagian atau semua pelaburan awal anda. Jangan melaburkan wang yang anda tidak mampu untuk kehilangan. Didik diri anda tentang risiko yang berkaitan dengan perdagangan pertukaran asing, dan dapatkan nasihat daripada penasihat bebas kewangan atau cukai jika anda mempunyai sebarang pertanyaan mengenainya. Semua data dan maklumat yang disediakan adalah semata-mata untuk tujuan maklumat, dan bukan bertujuan untuk tujuan perdagangan atau nasihat. Prestasi masa lalu tidak semestinya menunjukkan hasil masa depan.